{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:31:45Z","timestamp":1778041905719,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ped Infect Dis"],"DOI":"10.1093\/jpids\/piw009","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T20:48:51Z","timestamp":1458593331000},"page":"piw009","source":"Crossref","is-referenced-by-count":13,"title":["Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria"],"prefix":"10.1093","author":[{"given":"Elias","family":"Iosifidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asimenia","family":"Violaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Michalopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Volakli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisavet","family":"Diamanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Koliouskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalampos","family":"Antachopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Drossou-Agakidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Sdougka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"2016032117340430000_piw009v1.1","doi-asserted-by":"crossref","unstructured":"Glasner C , Albiger B , Buist G et al . Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill 2013; 18.","DOI":"10.2807\/1560-7917.ES2013.18.28.20525"},{"key":"2016032117340430000_piw009v1.2","doi-asserted-by":"publisher","DOI":"10.1086\/595011"},{"key":"2016032117340430000_piw009v1.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x"},{"key":"2016032117340430000_piw009v1.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu069"},{"key":"2016032117340430000_piw009v1.5","doi-asserted-by":"publisher","DOI":"10.1086\/665709"},{"key":"2016032117340430000_piw009v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.02.009"},{"key":"2016032117340430000_piw009v1.7","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000339"},{"key":"2016032117340430000_piw009v1.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1289"},{"key":"2016032117340430000_piw009v1.9","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182804b49"},{"key":"2016032117340430000_piw009v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2013.04.008"},{"key":"2016032117340430000_piw009v1.11","first-page":"59","article-title":"Successful treatment of multidrug-resistant Escherichia coli bacteremia with tigecycline in an acute myeloid leukemia child","volume":"54","author":"Ozdemir","year":"2012","journal-title":"Turk J Pediatr"},{"key":"2016032117340430000_piw009v1.12","doi-asserted-by":"publisher","DOI":"10.4067\/S0716-10182012000300011"},{"key":"2016032117340430000_piw009v1.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3343-3"},{"key":"2016032117340430000_piw009v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2008.03.002"},{"key":"2016032117340430000_piw009v1.15","unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning. Available at: http:\/\/www.fda.gov\/drugs\/drugsafety\/ucm369580.htm. Accessed 2 January 2016."},{"key":"2016032117340430000_piw009v1.16","unstructured":"European Medicines Agency. Tigecycline, Summary of Product Characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000644\/WC500044508.pdf. Accessed 3 January 2016."},{"key":"2016032117340430000_piw009v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.01.006"},{"key":"2016032117340430000_piw009v1.18","doi-asserted-by":"publisher","DOI":"10.1186\/cc13858"},{"key":"2016032117340430000_piw009v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.12.010"},{"key":"2016032117340430000_piw009v1.20","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22527"},{"key":"2016032117340430000_piw009v1.21","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-12-19"},{"key":"2016032117340430000_piw009v1.22","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31829eca34"},{"key":"2016032117340430000_piw009v1.23","doi-asserted-by":"crossref","unstructured":"De Luca M , Angelino G , Calo Carducci FI et al . Multidrug-resistant Acinetobacter baumannii infection in children. BMJ Case Rep 2011; 2011.","DOI":"10.1136\/bcr.02.2011.3807"},{"key":"2016032117340430000_piw009v1.24","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181c806d8"},{"key":"2016032117340430000_piw009v1.25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/INF.0b013e3181e83a85","article-title":"Pediatric acute pancreatitis related to tigecycline","volume":"29","author":"Prot-Labarthe","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"2016032117340430000_piw009v1.26","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318279eec2"},{"key":"2016032117340430000_piw009v1.27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01232-12"},{"key":"2016032117340430000_piw009v1.28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijantimicag.2014.07.014","article-title":"High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections","volume":"45","author":"Routsi","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"2016032117340430000_piw009v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.09.160"},{"key":"2016032117340430000_piw009v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv086"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/6\/2\/123\/17695539\/piw009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T16:44:45Z","timestamp":1567701885000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article-lookup\/doi\/10.1093\/jpids\/piw009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":30,"alternative-id":["10.1093\/jpids\/piw009"],"URL":"https:\/\/doi.org\/10.1093\/jpids\/piw009","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}